Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Ginger (Zingiber Officinale) Supplementation on Clinical, Biochemical, and Anthropometric Parameters in Patients With Multiple Sclerosis: A Double-Blind Randomized Controlled Trial Publisher Pubmed



Foshati S1 ; Poursadeghfard M2 ; Heidari Z3 ; Amani R1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Department of Biostatistics and Epidemiology, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Food and Function Published:2023


Abstract

Introduction: different lines of evidence have shown that ginger administration may be beneficial for patients with multiple sclerosis (MS). Therefore, we aimed to investigate the effect of ginger supplementation on disability, physical and psychological quality of life (QoL), body mass index (BMI), neurofilament light chain (NfL), interlukin-17 (IL-17), matrix metalloproteinase-9 (MMP-9), and neutrophil to lymphocyte ratio (NLR) in patients with relapsing-remitting MS. Methods: this was a 12 week double-blind parallel randomized placebo-controlled trial with a 3 week run-in period. The treatment (n = 26) and control (n = 26) groups received 500 mg ginger and placebo (corn) supplements 3 times daily, respectively. Disability was evaluated using the Expanded Disability Status Scale (EDSS). QoL was rated using the Multiple Sclerosis Impact Scale (MSIS-29). BMI was calculated by dividing weight by height squared. Serum levels of NfL, IL-17, and MMP-9 were measured using the enzyme-linked immunosorbent assay. NLR was determined using a Sysmex XP-300™ automated hematology analyzer. All outcomes were assessed before and after the intervention and analyzed using the intention-to-treat principle. Results: in comparison with placebo, ginger supplementation caused a significant reduction in the EDSS (−0.54 ± 0.58 vs. 0.08 ± 0.23, P < 0.001), the MSIS-29 physical scale (−8.15 ± 15.75 vs. 4.23 ± 8.46, P = 0.001), the MSIS-29 psychological scale (−15.71 ± 19.59 vs. 6.68 ± 10.41, P < 0.001), NfL (−0.14 ± 0.97 vs. 0.38 ± 1.06 ng mL−1, P = 0.049), IL-17 (−3.34 ± 4.06 vs. 1.77 ± 6.51 ng L−1, P = 0.003), and NLR (−0.09 ± 0.53 vs. 0.53 ± 1.90, P = 0.038). Nevertheless, the differences in BMI and MMP-9 were not significant between the groups. Conclusion: ginger supplementation may be an effective adjuvant therapy for patients with relapsing-remitting MS. © 2023 The Royal Society of Chemistry.
Related Docs
View other Related Docs
1. The Efficacy and Safety of Ginger Supplementation in Patients With Multiple Sclerosis: A Rationale and Study Protocol for a Double-Blind Randomized Controlled Trial, Health Science Reports (2023)
2. The Effects of Ginger Supplementation on Common Gastrointestinal Symptoms in Patients With Relapsing-Remitting Multiple Sclerosis: A Double-Blind Randomized Placebo-Controlled Trial, BMC Complementary Medicine and Therapies (2023)
3. Co-Supplementation of Synbiotics and Anti-Inflammatory-Antioxidant Rich Diet in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Mediterranean Journal of Nutrition and Metabolism (2024)
4. Potential of Modified Mediterranean Diet to Improve Quality of Life and Fatigue Severity in Multiple Sclerosis Patients: A Single-Center Randomized Controlled Trial, International Journal of Food Properties (2020)
5. The Effect of Zingiber Officinale Extract on Preventing Demyelination of Corpus Callosum in a Rat Model of Multiple Sclerosis, Iranian Biomedical Journal (2022)
6. Modified Mediterranean Diet V. Traditional Iranian Diet: Efficacy of Dietary Interventions on Dietary Inflammatory Index Score, Fatigue Severity and Disability in Multiple Sclerosis Patients, British Journal of Nutrition (2022)
7. Neuroimaging Markers and Disability Scales in Multiple Sclerosis: A Systematic Review and Meta-Analysis, PLoS ONE (2024)
8. Effect of Ginger (Zingiber Officinale) on Blood Glucose and Lipid Concentrations in Diabetic and Hyperlipidemic Subjects: A Meta-Analysis of Randomized Controlled Trials, Journal of Functional Foods (2017)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (73)
Masoud Etemadifar (48)
Other Related Docs
9. A Mediterranean-Type Diet Improved Systemic Inflammation in Multiple Sclerosis Patients, As Compared to the Traditional Iranian Diet: A Single-Center Randomized Controlled Trial, Mediterranean Journal of Nutrition and Metabolism (2021)
10. Effects of Anti-Inflammatory-Antioxidant-Rich Diet and Co-Supplemented Synbiotics Intervention in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Single-Blind Randomized Clinical Trial, Nutritional Neuroscience (2023)
11. Efficacy and Safety of Peginterferon Beta-1A Compared to Interferon Beta-1A in Relapsing Remitting Multiple Sclerosis Patients: A Phase 3, Randomized, Non-Inferiority Clinical Trial (Pegintegrity), Multiple Sclerosis and Related Disorders (2024)
12. Mri Features and Disability in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Neuroradiology (2024)
13. Effect of Ginger (Zingiber Officinale) on Inflammatory Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Cytokine (2020)
14. Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial, International Journal of Preventive Medicine (2020)
15. Factors Associated With Community Integration in People With Multiple Sclerosis With Mild and Moderate Levels of Disability: A Cross-Sectional Study, International Journal of Therapy and Rehabilitation (2024)
16. The Effects of Ginger Supplementation on Markers of Inflammatory and Oxidative Stress: A Systematic Review and Meta-Analysis of Clinical Trials, Phytotherapy Research (2020)
17. Dysphagia in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: A Comparison of Frequency, Severity, and Effects on Quality of Life, Multiple Sclerosis and Related Disorders (2024)
18. Impact of the Covid-19 Pandemic on the Psychological Status and Cortisol Level of Multiple Sclerosis Patients, Neuropsychological Rehabilitation (2023)
19. Comparable Efficacy and Safety of Teriflunomide Versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis, Neurology Research International (2021)
20. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
21. Association Between Dietary Inflammatory Index and Risk of Demyelinating Autoimmune Diseases: A Cross-Sectional Study, International Journal for Vitamin and Nutrition Research (2024)
22. Fatigue, Depression, and Health-Related Quality of Life in Patients With Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2012)
23. Association of Helicobacter Pylori With Multiple Sclerosis: Protective or Risk Factor?, Current Journal of Neurology (2020)
24. Does Ginger Supplementation Lower Blood Pressure? a Systematic Review and Meta-Analysis of Clinical Trials, Phytotherapy Research (2019)
25. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
26. Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (Ms)-A Longitudinal and Pilot Study, Frontiers in Psychiatry (2018)
27. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis, JAMA - Journal of the American Medical Association (2019)
28. Association of Dietary Patterns With Systemic Inflammation, Quality of Life, Disease Severity, Relapse Rate, Severity of Fatigue and Anthropometric Measurements in Ms Patients, Nutritional Neuroscience (2020)
29. Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial, NeuroImmunoModulation (2014)
30. Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review, Advances in Experimental Medicine and Biology (2021)
31. Ginger As an Anticolorectal Cancer Spice: A Systematic Review of in Vitro to Clinical Evidence, Food Science and Nutrition (2023)
32. Cancer and Mortality Risks Among People With Multiple Sclerosis: A Population-Based Study in Isfahan, Iran, PLoS ONE (2024)
33. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients With Multiple Sclerosis: A Phase Iv, Post-Marketing, Prospective, Multicenter Study, Archives of Iranian Medicine (2023)
34. Anti-Inflammatory-Antioxidant Modifications and Synbiotics Improved Health-Related Conditions in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Complementary Therapies in Clinical Practice (2023)
35. Validity and Reliability of the Persian Version of Recce Stigma Scale in People With Multiple Sclerosis and Its Impact on Quality of Life, BMC Neurology (2024)
36. Sexual Function and Related Predictors in Male With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Journal of Sexual Medicine (2025)
37. Confirmed Disability Progression As a Marker of Permanent Disability in Multiple Sclerosis, European Journal of Neurology (2022)
38. Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials, Heliyon (2024)
39. The Effect of Mindfulness-Based Stress Reduction (Mbsr) Therapy on Quality of Life in Women With Multiple Sclerosis, Ahvaz, Iran, Journal of Caring Sciences (2019)
40. Comparison of the Effect of Aspirin and Amantadine for the Treatment of Fatigue in Multiple Sclerosis: A Randomized, Blinded, Crossover Study, Neurological Research (2012)
41. Comparison of the Efficacy and Side Effects of Ifn Beta 1-A (Rebif) and a Biosimilar Product (Recigen) in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2012)
42. The Frequency of Cognitive Dysfunction Among Multiple Sclerosis Patients With Mild Physical Disability, Journal of Isfahan Medical School (2012)
43. Comparing Body Image in Ms Patients and Healthy Individuals, International Journal of Body, Mind and Culture (2020)
44. Comparison of Cognitive Rehabilitation Versus Donepezil Therapy on Memory Performance, Attention, Quality of Life, and Depression Among Multiple Sclerosis Patients, Neurology Research International (2020)
45. Anti-Cd20 Therapies for Pediatric-Onset Multiple Sclerosis: A Systematic Review, Multiple Sclerosis and Related Disorders (2024)
46. Th1, Th2 and Th17 Cytokine Profile in Patients With Multiple Sclerosis Following Treatment With Rapamycin, Iranian Journal of Immunology (2016)
47. The Effectiveness of Natalizumab Vs Fingolimod–A Comparison of International Registry Studies, Multiple Sclerosis and Related Disorders (2021)
48. Barriers to Quality of Life in Patients With Multiple Sclerosis: A Qualitative Study, BMC Neurology (2022)
49. The Role of Nutritional Factors During Adolescence in Multiple Sclerosis Onset: A Population-Based Incident Case–Control Study, Nutritional Neuroscience (2021)
50. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years, Neurology (2021)